Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating venetoclax in combination with the CACAG regimen for newly diagnosed acute myeloid leukemia has completed enrollment (status: completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CACAG regimen
  • Venetoclax (venetoclax)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED